Yong Yu

636 total citations
55 papers, 483 citations indexed

About

Yong Yu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yong Yu has authored 55 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 17 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Yong Yu's work include Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (8 papers) and Immune Cell Function and Interaction (6 papers). Yong Yu is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (8 papers) and Immune Cell Function and Interaction (6 papers). Yong Yu collaborates with scholars based in China, United States and Philippines. Yong Yu's co-authors include Jianhui Tian, Yizhuo Zhang, Lei An, Chen Tian, Hongliang Yang, Haifeng Zhao, Kai Miao, Zhonghong Wu, Kun Tan and Linlin Sui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Yong Yu

52 papers receiving 479 citations

Peers

Countries citing papers authored by Yong Yu

Since Specialization

Citations

This map shows the geographic impact of Yong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yu more than expected).

Fields of papers citing papers by Yong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yu. The network helps show where Yong Yu may publish in the future.

Co-authorship network of co-authors of Yong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Yu. A scholar is included among the top collaborators of Yong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Yu. Yong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma 2021 ·Journal of Cellular and Molecular Medicine ·(unknown), Yizhuo Zhang, (unknown), (unknown), Yueyang Li, Yong Yu, Yafei Wang, Chen Tian	3
2	Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma 2021 ·Clinical and Experimental Medicine ·Zhengzi Qian, (unknown), Xinyuan Wang, (unknown), Yafei Wang, Yong Yu, Xiaofang Wang, Zhigang Zhao, Hongliang Yang, Peng Ge, Tingting Ding, Qiong-Li Zhai, Haifeng Zhao	8
3	Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients 2021 ·Scientific Reports ·Chen Tian, Yueyang Li, Su Liu, Zehui Chen, Yizhuo Zhang, Yong Yu, Hongliang Yang, Haifeng Zhao, Zhigang Zhao, Yuan Tian, Yafei Wang	3
4	A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified 2018 ·Leukemia Research ·Qian Li, Shuang Gao, Jing Ma, Su Liu, (unknown), Lin Chen, Han Li, Xue Wang, Dongying Li, (unknown), Zhigang Zhao, Xiaofang Wang, Yong Yu, Yizhuo Zhang, (unknown)	5
5	High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China 2017 ·Annals of Hematology ·Chaoyu Wang, Bing Xia, (unknown), Haifeng Zhao, Hongliang Yang, Zhigang Zhao, Xiaofang Wang, Yafei Wang, Yong Yu, Yizhuo Zhang	27
6	[Effect of Rigorous Staging at the First Diagnosis on Prognosis of Patients with Follicular Lymphoma]. 2017 ·PubMed ·Lu Wang, Bei Yan, Yong Yu, Yafei Wang, Hongliang Yang, Haifeng Zhao, Xiaofang Wang, Xiaoxiong Wu, Wan-Ming Da, Su‐Xia Li, Yizhuo Zhang	0
7	Effect and safety of probiotics combined early enteral nutrition on severe acute pancreatitis patients 2017 ·Biomedical Research-tokyo ·Ping Wu, Yong Yu, Liang Li, Weijia Sun	7
8	The Lymphocyte–Monocyte Ratio and the Platelet–Lymphocyte Ratio at Diagnosis as Independent Prognostic Factors in Primary Gastrointestinal Diffuse Large B Cell Lymphoma 2016 ·Indian Journal of Hematology and Blood Transfusion ·Pan Zhao, Li Zang, Xiaoying Zhang, Ya‐Fang Chen, Hongliang Yang, Haifeng Zhao, Yong Yu, Yafei Wang, Yizhuo Zhang, (unknown)	11
9	ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy 2016 ·OncoTargets and Therapy ·Chen Tian, Yong Yu, (unknown), Lei Zhu, Yizhuo Zhang, Hongliang Yang	6
10	A case report of primary cutaneous natural killer/T-cell lymphoma 2016 ·Molecular and Clinical Oncology ·Chen Tian, Yong Yu, Yizhuo Zhang	3
11	Dynamic integrated analysis of DNA methylation and gene expression profiles inin vivoandin vitrofertilized mouse post-implantation extraembryonic and placental tissues 2016 ·Molecular Human Reproduction ·Kun Tan, Zhenni Zhang, Kai Miao, Yong Yu, Linlin Sui, Jianhui Tian, Lei An	28
12	HES1 is an independent prognostic factor for acute myeloid leukemia 2015 ·OncoTargets and Therapy ·Chen Tian, (unknown), Tengteng Wang, Yafei Wang, Yizhuo Zhang, Xiaofang Wang, Yong Yu	6
13	Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma 2015 ·Annals of Diagnostic Pathology ·Xiaofang Wang, Xiangli Li, Xiaoying Zhang, Li Zang, Hongliang Yang, (unknown), Haifeng Zhao, Qian Li, Bing Xia, Yong Yu, Yafei Wang, Zhigang Zhao, Yizhuo Zhang	14
14	Dynamic Proteomic Profiles of In Vivo- and In Vitro-Produced Mouse Postimplantation Extraembryonic Tissues and Placentas1 2014 ·Biology of Reproduction ·Linlin Sui, Lei An, Kun Tan, Zhuqing Wang, Shumin Wang, Kai Miao, (unknown), Tao Li, (unknown), Yong Yu, (unknown), Qian Liu, Xing Lei, Zhonghong Wu, Zhuocheng Hou, Jianhui Tian	27
15	Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy 2013 ·OncoTargets and Therapy ·(unknown), Yizhuo Zhang, Zhengxing Wang, Xiaoxiong Wu, Yong Yu, Bei Yan	0
16	Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone 2013 ·Annals of Hematology ·Shanqi Guo, (unknown), Hongliang Yang, Yong Yu, Yafei Wang, Jin Zhang, Guowen Wang, Lianyu Zhang, Baocun Sun, Yizhuo Zhang	7
17	Treatment of porcine donor cells and reconstructed embryos with the antioxidant melatonin enhances cloning efficiency 2012 ·Journal of Pineal Research ·Yunwei Pang, Lei An, Peng Wang, Yong Yu, (unknown), Xiaohong Wang, (unknown), (unknown), Meiling Yang, (unknown), Zhonghong Wu, Jianhui Tian	34
18	Association of a missense mutation in the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) with superovulation traits in Chinese Holstein heifers 2012 ·Journal of Animal Science and Biotechnology ·Yong Yu, Yunwei Pang, Haichao Zhao, Xiaoling Xu, Zhonghong Wu, Lei An, Jianhui Tian	9
19	[Significance of TIMP-1 and nm-23 expressions in HER-2-positive breast cancer]. 2012 ·PubMed ·Jun Liu, Yan Yang, (unknown), Yong Yu, Lin Gu	2
20	Enhancer ofSplit [E(spl)D] is a gro-independent, hypermorphic mutation inDrosophila 1999 ·Developmental Genetics ·Anja C. Nagel, Yong Yu, Anette Preiss	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact